Hikma Pharmaceuticals (HIK.L)

LSE 8 marketed ·

Quick facts

TickerHIK.L (LSE)

Marketed products

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: